论马兜铃酸与含马兜铃酸的中药

论述含马兜铃酸中药与西药马兜铃酸，以及单味合马兜铃酸中药与其复方的关系，建议对合马兜铃酸中药进行多学科综合基础研究，提出合马兜铃酸中药的不良反应监测、质量控制途径与方法，争取在国际范围内逐步用AAN来取代CHN。     

论马兜铃酸与含马兜铃酸的中药

论述含马兜铃酸中药与西药马兜铃酸,以及单味含马兜铃酸中药与其复方的关系,建议对含马兜铃酸中药进行多学科综合基础研究,提出含马兜铃酸中药的不良反应监测、质量控制途径与方法,争取在国际范围内逐步用AAN来取代CHN。     

我国中药材生产质量管理中存在的问题与对策

为推动完善中药材质量管理体系、促进中药材产业高质量发展,对中药材种植过程中投入品使用、加工、存储、质量等级标准、质量追溯体系等方面的现状及标准缺乏等问题进行归纳分析,提出应加强中药材质量监管、完善质量标准、加快良种繁育及搭建合作平台的建议,以期解决中药材质量管理过程中存在的问题,确保中药材的安全性与有效性,推动中药材产业高质量发展。     

Are there new therapeutic options for treating lung cancer based on herbal medicines and their metabolites?

ETHONOPHARMACOLOGICAL RELEVANCE: Lung cancer is one of the most lethal cancers in terms of mortality and incidence worldwide. Despite intensive research and investigation, treatment of lung cancer is still unsatisfactory due to adverse effects and multidrug resistance. Recently, herbal drugs have been recognized as one of attractive approaches for lung cancer therapy with little side effects. Furthermore, there are evidences that various herbal medicines have proven to be useful and effective in sensitizing conventional agents, prolonging survival time, preventing side effects of chemotherapy, and improving quality of life (QoL) in lung cancer patients. AIM AND METHODS OF THE STUDY: Nevertheless, the underlying molecular targets and efficacy of herbal medicines in lung cancer treatment still remain unclear. Thus, we reviewed traditionally used herbal medicines and their phytochemicals with antitumor activity against lung cancer from peer-reviewed papers through Scientific Database Medline, Scopus and Google scholar. CONCLUSIONS: We suggest that herbal medicines and phytochemicals can be useful anti-cancer agents for lung cancer treatment by targeting molecular signaling involved in the regulation of angiogenesis, metastasis and severe side effects, only provided quality control and reproducibility issues were solved.     

中药饮片质量安全问题分析及对策探讨

中药材是中药饮片及中成药的原料来源,当前对中药材市场难以形成有效的监管,中药饮片质量难以保证,本文通过对当前中药饮片中存在的质量安全问题进行逐一分析,并提出相应的解决措施,旨在提高中药饮片质量,保障临床用药的安全性和有效性。     

基于木通皂苷探讨中药质量评价用对照提取物研究

在分析总结中药对照提取物应用现状的基础上,提出中药质量评价用对照提取物根据用途不同,分为3类:①药材或挥发油对照提取物,用于原药材提取物或含原药材的中成药薄层鉴别;②组分对照提取物,用于某类组分鉴别或色谱峰定位;③标示了待测成分含量的对照提取物,可用于样品的定量分析。针对第3类对照提取物,以木通皂苷为例,从制备工艺、成分鉴定和含量分析等方面探讨了其研制思路和方法。     

中药炒焦物质基础及其质量评价研究思考与实践

中药炒焦后原有的有效或指标成分破坏或降低,但药理作用并不降低或有所增强,现有的有关物质基础的研究不能解释炒焦后药物的性味与功效等的变化。同时,对炒焦饮片的质量评价缺乏具有客观、专属性的评价指标,不能反映中药炒焦饮片的特点。因此如何打破炒焦研究的瓶颈,进一步创新、深入地研究中药炒焦物质基础,是业内学者面临的共同问题。笔者结合前期研究发现,提出通过对Maillard反应的研究来阐明炒焦物质基础及原理和建立适合炒焦饮片特点的专属质量评价指标的科学构想,并对此进行了相关研究。     

中药材种植溯源系统开发

中药质量和安全直接影响着整个中医药行业的发展,建立与完善中药质量追溯体系将对中药质量的提高发挥着决定性作用。中药材种植溯源系统作为中药质量追溯体系的重要组成部分,克服现有技术中无法实现中药材种植全流程信息可追溯、可监控及可查询的不足,采用物联网等技术,通过对中药种植环节重要信息的记录、查询及溯源,实现中药材种植全流程的追踪和监管,是实现中药来源可查、去向可追、责任可究,强化全过程质量安全管理与风险控制的有效措施。     

产舒康颗粒薄层鉴别研究

目的产舒康颗粒质量控制方法探讨。方法采用薄层色谱法。对产舒康颗粒中4种中药对照鉴别。结果在产舒康颗粒中检出当归、川芎、胎盘、甘草。结论薄层色谱法可用于产舒康颗粒中4种中药的鉴别。     

中药挥发油质量控制的现状、问题与对策

中药挥发油的质量稳定是保证其发挥临床疗效及安全性的前提。目前,中药挥发油的质量参差不齐,同种药材不同产地、同种药材不同厂家、同种药材不同批次的中药挥发油都存在较大质量差异。对中药挥发油质量控制的现状及问题进行了分析,并提出了中药材种植与品种规范化、加工过程规范化、投料部位标准化、提取工艺标准化、提取设备标准化等对策,同时简要分析了挥发油在中成药中的应用现状及质量控制,以期为有效控制中药挥发油及其中成药的质量提供参考。     

中药生产过程质量生物评控方法研究——以板蓝根颗粒为例

针对中药材-中间体-成品一体化质量管理体系中存在的方法学"短板效应",借鉴过程控制理念,从中药生产实际出发,建立符合中药特点的生产过程质量控制新策略、新方法。以疗效确切、临床应用广泛的板蓝根颗粒为示例,采用性状鉴别、指标成分含量测定、化学指纹图谱和生物测定技术分别对板蓝根药材-中间体(水提醇沉)-成品进行质量评控,以化学信息转移率和生物效价转移率为指标,考察上述不同评控方法的效力性与传递性,最终建立基于化学组分分析-生物测定关联分析的板蓝根颗粒生产过程质量控制方法,有效地解决目前板蓝根颗粒生产厂家繁多、质量参差不齐的现状,以确保与提升其临床疗效,亦为中药生产过程质量控制的方法学构建提供了研究基础。     

中药材专利技术现状及发展趋势

专利技术直接代表市场经济下的技术发展趋势,专利文献是技术情报、法律情报和经济情报的重要来源.本研究通过检索统计中国专利文献,较为全面地分析了目前中药材所涉及技术领域的总体发展概况,对与中药材产业发展紧密相关的生物技术、质量评价技术、炮制技术和栽培育种技术等专利的状况和具体的技术内容进行分类评述,进一步指出了中药材技术发展的若干趋势,并从专利申请策略、技术转化和保护方式方面提出加强中药材专利保护的建议.     

施肥与中药材质量相关性研究概况

文章综述了施肥对中药材质量影响的研究概况,分析了科学合理施肥是提高中药材质量的重要环节,指出了目前中药材施肥研究中存在的不足之处,并根据GAP的要求,对中药材的发展提出相应的建议。     

HPLC测定中药材玄参中有效成分的含量分析

[目的]建立高效液相色谱法(HLPC)测定中药材玄参中5种有效成分的含量,为玄参药材的质量控制提供依据。[方法]采用高效液相色谱法(HLPC)法,测定玄参中哈巴苷、哈巴俄苷、肉桂酸、麦角甾苷、安格洛苷C的含量。[结果]不同产地小儿中药材玄参中有效成分的含量不同,以浙江产玄参药材中5种成分的含量较高,而河南、山东产玄参药材有效成分的含量较低。[结论]应用HLPC测定不同产地中药材玄参中有效成分的含量,其方法准确可靠,重现性、专属性均较好,可用于中药材玄参的质量控制。     

Herbal medicine: Who cares? The changing views on medicinal plants and their roles in British lifestyle

Herbal medicines are not only widely used but also contentious health care products. Currently, little is known about the products' place in people's health care strategies and their views about such products. The aims of the study are to gain insight into the public's perception of herbal medicine/general use of herbs for health, as well as on the growing of plants for medicine. Core to the research was a survey that covered participants' views about herbal medicines. Data were collected online and from visitors at the Eden Project, as well as some other garden events. Survey responses were categorized and analysed using Qualtrics. Overall, 408 participants participated though numbers varied across questions. Results show that herbal medicines are popular, particularly amongst the 36‐ to 55‐year‐old age group. Participants mostly used herbal medicines for minor self‐limiting conditions. Popular reasons for use included that plant medicines are natural and have fewer side effects, as well as for a few changing relationship with conventional medicines. Around a third of participants grew their own plants for health care. This is the first larger U.K.‐based survey indicating a wide use of such products, and it is therefore recommended that there is an increase in quality control and wider regulation. Access to high‐quality products should be prioritized.     

我国中药材及饮片的质量情况及有关问题分析

 中药材种植养殖环节标准化、规范化落实不到位,采收、产地初加工操作不规范,中药饮片生产及流通环节违法染色增重、掺杂使假,中药材专业市场以次充好、以假充真、制假售假、违法经营中药饮片和其他药品等现象严重影响中药材及饮片质量安全,危害公众健康。以国家食品药品监督管理总局2013年组织开展药品“两打两建”专项行动以来各省市药品监管部门检查和抽验工作为基础,对发现的中药材及饮片质量情况进行汇总和分析,以期反映我国中药材及饮片的质量现状,为相关部门监管政策的制定、标准修订和完善提供参考。     

������ҩ��Ƭ��ͷ���ɣ������΢������Ⱦ�ļ�⼰����

??OBJECTIVE To investigate the microbial contamination in Anemones Raddeanae Rhizoma and Taxilli Herba to provide a reference for microbiological examination of Chinese herbal medicines. METHODS Anemones Raddeanae Rhizoma and Taxilli Herba were analyzed according to the Chinese Pharmacopoeia 2015 Edition (publicity draft) and the methods of National Institutes for Food and Drug Control for thermoduric bacteria and specified microoganisms. RESULTS The microbial contamination in 23 batches samples of the two Chinese herbal medicines was serious. CONCLUSION There is an urgent need to control the microbial contamination of Chinese herbal medicines and Chinese medicines to improve their quality.     

中药材提取物的研究进展

中药材是中医临床用药和各种中药制剂研究开发的物质基础,但现在中药材市场相对比较混乱,一些以次充好、以假乱真的事件依然存在,而中药材质量的好坏,直接影响中成药与饮片的质量、疗效,同时也是中药材市场的生命所在。中药的质量控制,除了评价其外观性状,还要评价其化学成分、活性物质等内在品质,中药质量标准的制定关系着中医药能否健康发展或存在。以中药的方法研究中药,用中药药效组分标定中药,从而建立适用于中药的质量标准,这是未来中药发展的必然趋势。     

药材中二氧化硫残留量检测及方法研究

目的测定市售中药饮片中二氧化硫残留情况,为中药材具体品种制定限量提供参考。方法采用酸蒸馏碘滴定法测定二氧化硫的含量。结果 10个中药材样品全部都有二氧化硫残留。结论目前市售药材中二氧化硫普遍偏高,有关部门应尽快制订有效措施加以控制。     

Current Status of Herbal Drug Standards in the Indian Pharmacopoeia

The benefits of herbal drugs were well understood way back. They have been used for the promotion of health and medical purposes – in disease conditions. It is a conventional belief that herbal drugs have no side effects, are cheaper and locally available. Among Indian systems of medicines, herbs/herbal formulations are used to a larger extent. The quality control of the marketed herbs/herbal formulations is important for acquiring optimum therapeutic benefit as well as for expanding global outreach. Therefore, herbal drug standards are important. Reference standards, the Indian Pharmacopoeia Reference Substances especially the botanical reference substances and the phytochemical reference substances are required for comparison of quality of herbal drugs. The Indian Pharmacopoeia Commission has initiated the process of providing Indian Pharmacopoeia Reference Substances to the stakeholders. Therefore, this article provides an overview of the history and the status of herbal drug standards in the current and forthcoming issues of Indian Pharmacopoeia. In Indian Pharmacopeia, efforts have been made for the harmonization of standards with international counterparts wherever possible. Copyright © 2017 John Wiley & Sons, Ltd.